Classification Term: 168303

Monoacylglycerophosphoinositolglycans [GP1504] (ontology term: 6b14ca0a53c1b2f2821fbb39fc0620b7)

Monoacylglycerophosphoinositolglycans [GP1504]

found 48 associated metabolites at sub_class metabolite taxonomy ontology rank level.

Ancestor: Glycerophosphoinositolglycans [GP15]

Child Taxonomies: There is no child term of current ontology term.

LPIM1 16:0

2-O-(alpha-D-Manp)-(1-hexadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C31H59O17P (734.349)

LPIM1 17:0

2-O-(alpha-D-Manp)-(1-heptadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C32H61O17P (748.3646)

LPIM1 18:0

2-O-(alpha-D-Manp)-(1-octadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C33H63O17P (762.3803)

LPIM1 18:1

2-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-sn-glycero-3-phospho-1-myo-inositol)

C33H61O17P (760.3646)

LPIM1 18:2

2-O-(alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-1-myo-inositol)

C33H59O17P (758.349)

LPIM1 19:0

2-O-(alpha-D-Manp)-(1-nonadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C34H65O17P (776.3959)

LPIM1 19:1

2-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-sn-glycero-3-phospho-1-myo-inositol)

C34H63O17P (774.3803)

LPIM1 19:2

2-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-sn-glycero-3-phospho-1-myo-inositol)

C34H61O17P (772.3646)

LPIM2 16:0

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp)-(1-hexadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C37H69O22P (896.4018)

LPIM2 17:0

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp)-(1-heptadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C38H71O22P (910.4174)

LPIM2 18:0

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp)-(1-octadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C39H73O22P (924.4331)

LPIM2 18:1

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp)-(1-(9Z-octadecenoyl)-sn-glycero-3-phospho-1-myo-inositol)

C39H71O22P (922.4174)

LPIM2 18:2

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-1-myo-inositol)

C39H69O22P (920.4018)

LPIM2 19:0

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp)-(1-nonadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C40H75O22P (938.4487)

LPIM2 19:1

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp)-(1-(9Z-nonadecenoyl)-sn-glycero-3-phospho-1-myo-inositol)

C40H73O22P (936.4331)

LPIM2 19:2

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-sn-glycero-3-phospho-1-myo-inositol)

C40H71O22P (934.4174)

LPIM3 16:0

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C43H79O27P (1058.4546)

LPIM3 17:0

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C44H81O27P (1072.4703)

LPIM3 18:0

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C45H83O27P (1086.4859)

LPIM3 18:1

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-sn-glycero-3-phospho-1-myo-inositol)

C45H81O27P (1084.4703)

LPIM3 18:2

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-1-myo-inositol)

C45H79O27P (1082.4546)

LPIM3 19:0

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C46H85O27P (1100.5016)

LPIM3 19:1

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-sn-glycero-3-phospho-1-myo-inositol)

C46H83O27P (1098.4859)

LPIM3 19:2

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-sn-glycero-3-phospho-1-myo-inositol)

C46H81O27P (1096.4703)

LPIM4 16:0

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C49H89O32P (1220.5074)

LPIM4 17:0

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C50H91O32P (1234.5231)

LPIM4 18:0

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C51H93O32P (1248.5387)

LPIM4 18:1

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-sn-glycero-3-phospho-1-myo-inositol)

C51H91O32P (1246.5231)

LPIM4 18:2

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-1-myo-inositol)

C51H89O32P (1244.5074)

LPIM4 19:0

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C52H95O32P (1262.5544)

LPIM4 19:1

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-sn-glycero-3-phospho-1-myo-inositol)

C52H93O32P (1260.5387)

LPIM4 19:2

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-sn-glycero-3-phospho-1-myo-inositol)

C52H91O32P (1258.5231)

LPIM5 16:0

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C55H99O37P (1382.5603)

LPIM5 17:0

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C56H101O37P (1396.5759)

LPIM5 18:0

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C57H103O37P (1410.5916)

LPIM5 18:1

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-sn-glycero-3-phospho-1-myo-inositol)

C57H101O37P (1408.5759)

LPIM5 18:2

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-1-myo-inositol)

C57H99O37P (1406.5603)

LPIM5 19:0

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C58H105O37P (1424.6072)

LPIM5 19:1

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-sn-glycero-3-phospho-1-myo-inositol)

C58H103O37P (1422.5916)

LPIM5 19:2

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-sn-glycero-3-phospho-1-myo-inositol)

C58H101O37P (1420.5759)

LPIM6 16:0

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-hexadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C61H109O42P (1544.6131)

LPIM6 17:0

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-heptadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C62H111O42P (1558.6287)

LPIM6 18:0

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-octadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C63H113O42P (1572.6444)

LPIM6 18:1

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-octadecenoyl)-sn-glycero-3-phospho-1-myo-inositol)

C63H111O42P (1570.6287)

LPIM6 18:2

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phospho-1-myo-inositol)

C63H109O42P (1568.6131)

LPIM6 19:0

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-nonadecanoyl-sn-glycero-3-phospho-1-myo-inositol)

C64H115O42P (1586.66)

LPIM6 19:1

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z-nonadecenoyl)-sn-glycero-3-phospho-1-myo-inositol)

C64H113O42P (1584.6444)

LPIM6 19:2

2-O-(alpha-D-Manp)-6-O-(alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp-1->6-alpha-D-Manp)-(1-(9Z,12Z-nonadecadienoyl)-sn-glycero-3-phospho-1-myo-inositol)

C64H111O42P (1582.6287)